12:00 AM
Oct 19, 2009
 |  BC Week In Review  |  Company News  |  Deals

Locus, Novartis deal

Locus will use its virtual fragment-based drug design technology to discover chemotypes...

Read the full 40 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >